Form 8-K - Current report:
SEC Accession No. 0001193125-24-255153
Filing Date
2024-11-12
Accepted
2024-11-12 07:30:32
Documents
17
Period of Report
2024-11-11
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d866073d8k.htm   iXBRL 8-K 30499
2 EX-99.1 d866073dex991.htm EX-99.1 10335
7 GRAPHIC g866073dsp005a.jpg GRAPHIC 14744
8 GRAPHIC g866073g1108222549723.jpg GRAPHIC 7806
  Complete submission text file 0001193125-24-255153.txt   237375

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20241111.xsd EX-101.SCH 3099
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20241111_def.xml EX-101.DEF 13865
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20241111_lab.xml EX-101.LAB 22896
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20241111_pre.xml EX-101.PRE 14703
20 EXTRACTED XBRL INSTANCE DOCUMENT d866073d8k_htm.xml XML 5991
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 241443305
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)